Cargando…
Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics
Thrombus formation remains a major cause of morbidity and mortality worldwide. Current antiplatelet and anticoagulant therapies have been effective at reducing vascular events, but at the expense of increased bleeding risk. Targeting proteins that interact with fibrinogen and which are involved in h...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625824/ https://www.ncbi.nlm.nih.gov/pubmed/34830419 http://dx.doi.org/10.3390/ijms222212537 |